[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: Call for input on digital rights management
- To: "'David Goodman '" <dgoodman@phoenix.Princeton.EDU>, "'liblicense-l@lists.yale.edu '" <liblicense-l@lists.yale.edu>
- Subject: RE: Call for input on digital rights management
- From: Jan Velterop <jan@biomedcentral.com>
- Date: Sun, 14 Jul 2002 17:38:43 EDT
- Reply-To: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
David, you got a point there. We don't worry about anthologies. All the primary research articles are available, for free, in open access, so if somebody wants to pay for a printed anthology you are putting together, so be it. If a profit-making commercial enterprise wants to use an article for sales promotion and reprints thousands of them, we suggest to them to make a contribution to a fund that allows authors to publish in open access. So far, companies have graciously done that. The amount we suggest is in the same order of magnitude as what they would have to pay for reprint permission elsewhere. We leave it to he author(s) of the article to decide whether to use the fund to pay for his or her own future papers in any of the open access journals BioMed Central publishes, to share it with fellow-authors from his or her institution who wish to publish in that way (putting it towards an institutional BioMed Central membership, which entitles to automatic waivers of Article Processing Charges), or to put it in a general fund, which is used to support authors from developing countries. Best, Jan -----Original Message----- From: David Goodman To: liblicense-l@lists.yale.edu Sent: 7/11/02 10:27 PM Subject: RE: Call for input on digital rights management Wait a minute, Jan. Do you mean that if I were to take selected excellent articles from your publications, and reprint them as an anthology, and sell them in hard copy for my own profit, you (and the authors) would consider this fair? Agreed, this very very rarely happens. Practically the only publisher who has in recent years done this on a more or less regular basis is Scientific American, which of course is not a primary research publication. But what if a profit-making commercial enterprise wanted to reprint 50,000 copies of an article involving one of their products and use it as a sales promotion? David Goodman Research Librarian and Biological Sciences Bibliographer Princeton University Library dgoodman @princeton.edu 609-258-7785 On Wed, 10 Jul 2002, Jan Velterop wrote: [SNIP] > All use is fair use. At least for research published by BioMed Central. > > Jan Velterop > Publisher BioMed Central
- Prev by Date: 2003 Subscription Prices from Portland Customer Services
- Next by Date: re: Permitted Use Clause
- Prev by thread: RE: Call for input on digital rights management
- Next by thread: L'Annee Philologique
- Index(es):